Skip to content

VCYT

Veracyte, Inc.

Stock

$45.81+1.62 (+3.67%)Close Oct 2, 2026

Income statement

LineLast 12 months202520242023202220212020201920182017201620152014201320122011
Revenue$562M$517M$446M$361M$297M$220M$117M$120M$92M$72M$65M$50M$38M$22M$12M$2.6M
Cost of revenue$159M$155M$148M$131M$121M——$36M$33M$28M$25M$21M$17M$13M$7.6M$2.9M
Gross profit$403M$363M$298M$230M$176M——$84M$59M$44M$40M$28M$22M$9.3M$4.0M−$280K
R&D$93M$71M$69M$57M$41M$30M$17M$15M$15M$14M$15M$13M$9.8M$7.8M$6.6M$6.7M
SG&A$202M$211M$206M$188M$171M$181M$89M$83M$65M$55M$52M$48M$41M$25M$16M$8.3M
Other operating expenses$2.2M$23M$6.7M$70M$5.4M——$1.8M$1.1M$1.1M$1.1M$800K————
Operating income$106M$58M$16M−$86M−$41M−$82M−$35M−$15M−$22M−$27M−$29M−$33M−$29M−$23M−$19M−$15M
Non-operating income$10M$10M$9.6M$9.2M$4.7M$254K$480K$2.5M−$767K−$4.5M−$2.6M−$234K−$394K−$2.4M$329K$866K
Pretax income$116M$68M$26M−$77M−$36M−$82M−$35M−$13M−$23M−$31M−$31M−$34M−$29M−$26M−$19M−$14M
Taxes$1.5M$1.8M$1.6M−$2.2M$133K−$6.1M$0$0−$1K$3K−$42K$4K−$27K$0$49K$45K
Net income$114M$66M$24M−$74M−$37M−$76M−$35M−$13M−$23M−$31M−$31M−$34M−$29M−$26M−$19M−$14M
Diluted EPS$1.39$0.82$0.31−$1.02−$0.51−$1.11−$0.66−$0.27−$0.62−$0.91−$1.09−$1.30−$1.36−$6.15−$28.68−$24.90
Diluted shares—80.6M78.2M72.6M71.5M67.9M53.2M46.1M37.0M33.9M28.8M26.0M21.6M4.2M650K580K
Revenue growth—+16.0%+23.5%+21.8%+35.1%+86.8%−2.4%+30.8%+27.9%+10.6%+31.5%+29.6%+74.5%+88.2%+339.6%—
Gross margin71.7%70.1%66.9%63.6%59.2%——70.0%64.0%60.8%60.9%56.6%56.5%42.4%34.8%−10.6%
Operating margin18.8%11.2%3.6%−23.8%−13.9%−37.3%−30.1%−12.6%−24.2%−36.9%−44.3%−67.6%−76.0%−105.9%−162.8%−577.2%
Net margin20.4%12.8%5.4%−20.6%−12.3%−34.4%−29.7%−10.5%−25.0%−43.1%−48.2%−68.1%−76.9%−116.9%−160.4%−546.1%

Revenue to net income